Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.
about
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)Atypical antipsychotics for aggression and psychosis in Alzheimer's diseaseQuetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trialRecommendations for the management of behavioral and psychological symptoms of dementia.Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies.Thioridazine for dementia.Impact of prescribed medications on patient safety in older people.Neuropsychiatric aspects of Alzheimer's disease.Psychosis and behavioural symptoms of dementia: defining the role of neuroleptic interventions.Presenile dementia syndromes: an update on taxonomy and diagnosis.Dementia with Lewy bodies: clinical characteristics and diagnostic criteria.Study protocol for the recreational stimulation for elders as a vehicle to resolve delirium superimposed on dementia (Reserve For DSD) trial.Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype.Defining diffuse Lewy body disease. Tetrad of symptoms distinguishes illness from other dementias.Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease.Slow Progression of Cognitive Dysfunction of Alzheimer's Disease in Sexagenarian Women with Schizophrenia.CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based studyAggression in persons with dementia: use of nursing theory to guide clinical practice.Behavioural symptoms of dementia in residential settings: a selective review of non-pharmacological interventions.Psychiatric and behavioral symptoms in Alzheimer's disease and other dementias: etiology and management.Relapse risk after discontinuation of risperidone in Alzheimer's disease.Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives.Prescribing in care homes: the role of the geriatricianManagement of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.Neuroleptic drugs in dementia: benefits and harm.Aggressive behaviour by people with dementia in residential care settings: a review.Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?Risperidone for the treatment of neuropsychiatric features in dementia.The use of aromatherapy to treat behavioural problems in dementia.Practical Protocol for Implementing Cognitive Stimulation in Persons with Delirium Superimposed on Dementia.Neurocognitive costs and benefits of psychotropic medications in older adults.Dementia of the Alzheimer type.Neuropsychiatric symptoms in dementia: importance and treatment considerations.Reminiscence groups for people with dementia and their family carers: pragmatic eight-centre randomised trial of joint reminiscence and maintenance versus usual treatment: a protocol.Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review.The assessment and management of behavioural manifestations of dementia: a review and results of a controlled trial.The relationship between anxiety disorders and age.Inappropriate behaviors and hypersexuality in individuals with dementia: An overview of a neglected issue.
P2860
Q21144654-EED9CD17-9AE0-45F6-8DC4-F5CAC8E83D4BQ24244504-2F803D15-61C6-4251-AB89-0A7DF0153829Q24555726-664E293A-10AB-47B7-8CBB-79698EE4D58EQ30327961-6B55A8DC-527E-429B-A72B-0245F8D0E90CQ33248004-769FF4E4-8B51-4857-80E3-74AEB799B992Q33635801-0B44808E-4DC6-45FF-A122-529072EA63FAQ33860727-74775B75-8EDD-45A7-B9ED-AB776F19E24DQ33908801-B77A9FD6-AF07-4D4D-9198-E8EDF8C288B7Q33949432-88BD744A-85C4-46E3-9665-E107D3B661ACQ34108175-5027CD3D-2704-4D44-B3FA-F0B592AC2542Q34465775-E0B47C4F-A1AB-43DD-A169-C98D07A6F486Q34649249-AA0F56B0-D8FB-4B0D-965F-DF92090C175FQ35029466-FCA71E72-9E2E-40B1-90F7-DB801BE2FBDAQ35042349-2F5847F5-3A00-4E68-B787-2F46B00F25BAQ35124987-E46E460B-D174-450C-9E7E-2F17C17D9746Q35135143-9A8CA22D-DFC7-4168-B50D-A440BA37E142Q35465836-B0C46687-773B-4BF8-BBFF-EDA35E8DC5CFQ35889701-FE7E5FE6-0113-4FD3-9D40-BD0F86E0661EQ35953332-C7DFC869-A399-454F-934F-70E7248EE2E0Q36003456-5D3D46EB-3F70-4E5E-A427-DE293CDA04FBQ36086070-5B953A0E-B213-4A4A-A4BF-85695A598FD3Q36244571-839004F4-09B5-4B21-99A0-51AB03487B45Q36375421-75DDB46A-EDB9-44FD-B14D-80D3FAFEEA9FQ36442311-9449480D-2D4E-4ED9-9692-5593BC97D7CBQ36443772-C7D14B35-2374-48D3-B098-20856C6C92FDQ36458299-58621A81-0F22-4B85-AFF2-7C3A5A33E0A1Q36484553-55DFCD9E-637D-4ADF-8D66-02DDB62518D7Q36590764-6E2ADA23-8A77-4A6F-A31C-24FF648A66E7Q36592621-DF8DB817-21DC-4885-BDEA-4ED0AEEE95F1Q36655157-CFFB5F45-32D6-48DA-9B8F-20FD03DF57C8Q36961800-635005B0-4C8F-4039-A27E-F084952DF4D3Q36974834-9FAB3C53-8126-4259-8B87-D7D8570BB4A1Q37001163-ED3DB98B-655F-474B-897B-686EED76EF0AQ37219298-C48B6192-0B3D-4CA0-803C-15351535F3C4Q37299919-969C47A7-B426-462B-9BE8-203B5F7786B5Q37316402-FB271FCC-BD2E-4BC7-B1F6-725020D67B6DQ37713670-3ABCA92C-AE35-4E6E-8116-28D02ABD893FQ38221165-17A85C3C-3490-4D46-82B6-7DEE5C0DD62AQ38552742-36617051-4A0D-47E1-98D9-FEB9C2F76896Q38917764-BA248325-572A-424E-B2F8-CCD5FCDC96A6
P2860
Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Do neuroleptic drugs hasten co ...... study with necropsy follow up.
@ast
Do neuroleptic drugs hasten co ...... study with necropsy follow up.
@en
type
label
Do neuroleptic drugs hasten co ...... study with necropsy follow up.
@ast
Do neuroleptic drugs hasten co ...... study with necropsy follow up.
@en
prefLabel
Do neuroleptic drugs hasten co ...... study with necropsy follow up.
@ast
Do neuroleptic drugs hasten co ...... study with necropsy follow up.
@en
P2093
P356
P1433
P1476
Do neuroleptic drugs hasten co ...... study with necropsy follow up.
@en
P2093
P304
P356
10.1136/BMJ.314.7076.266
P407
P577
1997-01-01T00:00:00Z